Medicine and Dentistry
Age
9%
Analysis
5%
Antibody
55%
Antibody Response
24%
Anticoagulation
6%
Antigen
43%
Assay
46%
Biological Marker
10%
Blood
9%
Blood Sampling
6%
Blood Stasis
28%
Body Mass Index
6%
Case Report
9%
Cells
9%
Cellular Immunity
9%
Coagulopathy
9%
COVID-19
90%
COVID-19 Vaccination
21%
COVID-19 Vaccine
13%
Cytokine Response
9%
Diagnosis
34%
Drug Dose Regimen
11%
Enzyme Linked Immunosorbent Assay
11%
Experience
9%
Extracellular Trap
7%
Fibrinogen
13%
Fibrinolysis
7%
Heparin
7%
Histone
7%
Hospital
9%
Humoral Immunity
22%
Immune Response
7%
Immune System
9%
Immunoassay
17%
Immunogenicity
9%
Immunoglobulin A
10%
Immunoglobulin G
22%
Immunoglobulin G Antibody
17%
Immunoglobulin M Antibody
9%
In Vitro
7%
Infection
43%
Inpatient
9%
Laboratory
27%
Laboratory Medicine
9%
Lung
9%
Messenger RNA
13%
Molecular Diagnosis
6%
mRNA Vaccine
11%
Neonates
9%
Neutralizing Antibody
66%
Neutrophil
16%
Nucleosome
9%
Observational Study
9%
Omicron Coronavirus Variant
10%
Patient
77%
Plasma
8%
Platelet
7%
Protein
17%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Reverse Transcription Polymerase Chain Reaction
5%
Septic Shock
9%
Serositis
6%
Serum
11%
Severe Acute Respiratory Syndrome Coronavirus 2
80%
Symptom
5%
Syndrome
18%
Systematic Review
9%
Therapeutic Procedure
13%
Thrombocytopenia
18%
Thromboembolism
6%
Thrombosis
23%
Transplantation
9%
Vaccine
50%
Virus
10%
Virus Neutralization
15%
Virus Nucleocapsid
15%
Wassermann Test
8%
Woman
18%
Immunology and Microbiology
Adoptive Immunity
9%
Antibody Response
14%
Antigen
55%
Binding Antibody
26%
Breakthrough Infection
23%
COVID-19
42%
Cross-Reactivity
5%
Dose
21%
Drug Dose Regimen
6%
Dynamics
15%
ELISA
10%
Experience
9%
Humoral Immunity
16%
Immune System
9%
Immunoassay
16%
Immunoassay
7%
Immunogenicity
9%
Immunoglobulin G Antibody
33%
Immunoglobulin M
6%
Immunoglobulin M Antibody
18%
Inflammation
9%
Influenza
9%
Kinetics
19%
Life
9%
Lung Transplantation
9%
Monospecific Antibody
73%
NETosis
10%
Neutralization
7%
Neutralizing Antibody
76%
Neutrophil Granulocyte
7%
Omicron Coronavirus Variant
25%
Pregnancy
6%
Recognition
9%
Respiratory Syncytial Virus
9%
Reverse Transcription Polymerase Chain Reaction
10%
Sample
51%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
14%
Time
12%
Titer
5%
Vaccine Efficacy
45%
Viral Load
13%
Virus Neutralization
6%
Virus Nucleocapsid
15%
Biochemistry, Genetics and Molecular Biology
Antibody
37%
Blood Level
9%
Coagulation
6%
Coronavirinae
9%
Dose
5%
Experience
9%
Fibrinolysis
12%
Hemostasis
28%
Heparin
8%
Histone
7%
Humoral Immunity
5%
Immunoglobulin G
13%
Immunoglobulin M
9%
Kinetics
17%
Laboratory Technique
9%
Life
6%
Molecular Array
9%
Neutralizing Antibody
9%
Nucleosome
9%
Protein
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Quantitative Technique
9%
Recognition
9%
Reverse Transcription Polymerase Chain Reaction
16%
Sample
38%
SARS Coronavirus
70%
Thrombin
13%
Time
7%
Virus Load
14%
Virus Nucleocapsid
6%